Aktis Oncology, Inc.

Aktis Oncology, Inc.

NNASDAQ:AKTS
15.82
USD
+0.97
(+6.53%)
-1.39EPS
1.78BMarket Cap
Dec 02Next Earn

Aktis Oncology, Inc. Documents

Q1 FY2026 · Presentation

5.5.26 - AKY-2519 Phase 1b Trial Update Conference Call Presentation · 16 pages

Read Aktis Oncology, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q1 FY2026 documents